Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myxoid/Round Cell Liposarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04044768
What this trial is testing

Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Synovial SarcomaMyxoid Liposarcoma
USWM CT, LLC 52
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT00633165
What this trial is testing

Brostallicin Clinical Trial for Myxoid Liposarcoma

Who this might be right for
Myxoid Liposarcoma
Systems Medicine LLC 24
Early research (Phase 1)UnknownNCT03600649
What this trial is testing

Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas

Who this might be right for
Ewing SarcomaMyxoid LiposarcomaSarcoma,Soft Tissue+8 more
Salarius Pharmaceuticals, LLC 50
Testing effectiveness (Phase 2)Study completedNCT02249949
What this trial is testing

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Who this might be right for
Liposarcoma
Alliance for Clinical Trials in Oncology 15
Early research (Phase 1)Ended earlyNCT03399448
What this trial is testing

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Who this might be right for
Multiple MyelomaMelanomaSynovial Sarcoma+1 more
University of Pennsylvania 3
Early research (Phase 1)Study completedNCT03450122
What this trial is testing

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Myxoid Liposarcoma+1 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271
What this trial is testing

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more
Sotio Biotech Inc. 7
Early research (Phase 1)Ended earlyNCT04526509
What this trial is testing

Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors

Who this might be right for
Neoplasms
Adaptimmune 12
Testing effectiveness (Phase 2)Study completedNCT06703346
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM CT, LLC 82
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
St. Jude Children's Research Hospital 139
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Not applicableNot Yet RecruitingNCT06526897
What this trial is testing

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

Who this might be right for
Adult Pleomorphic RhabdomyosarcomaAJCC Grade 2 SarcomaAJCC Grade 3 Sarcoma+20 more
ECOG-ACRIN Cancer Research Group 1,582
Testing effectiveness (Phase 2)Study completedNCT01532687
What this trial is testing

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+16 more
OHSU Knight Cancer Institute 54
Testing effectiveness (Phase 2)Study completedNCT02821507
What this trial is testing

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Who this might be right for
Conventional ChondrosarcomaMyxoid LiposarcomaMesenchymal Chondrosarcoma+1 more
Leiden University Medical Center 70
Testing effectiveness (Phase 2)WithdrawnNCT03397186
What this trial is testing

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaStage III Soft Tissue Sarcoma AJCC v7+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02609984
What this trial is testing

Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)

Who this might be right for
SarcomaMyxoid/Round Cell LiposarcomaSynovial Sarcoma+4 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 89
Testing effectiveness (Phase 2)Study completedNCT04794127
What this trial is testing

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.

Who this might be right for
Liposarcoma, MyxoidLiposarcoma, DedifferentiatedLiposarcoma, Round Cell
Mario Negri Institute for Pharmacological Research 10
Testing effectiveness (Phase 2)Looking for participantsNCT02275286
What this trial is testing

Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

Who this might be right for
Liposarcoma, MyxoidSarcoma, Soft TissueLeiomyosarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 199
Testing effectiveness (Phase 2)UnknownNCT05266196
What this trial is testing

A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)

Who this might be right for
Ewing SarcomaMyxoid LiposarcomaDesmoplastic Small Round Cell Tumor+6 more
Salarius Pharmaceuticals, LLC 10
Next Page